| Ministry/Agency | Ministry of Health Malaysia - National Pharmaceutical Regulatory Agency |
|---|---|
| Consultation Period | 16/01/2026 - 10/03/2026 Closed |
| Consultation Stage | Public Feedback |
| Classification | Professional, scientific and technical activities |
This public consultation aims to gather stakeholder feedback on the rebranding of the NPRA GLP Compliance Programme Manual to the Malaysian Guideline for NPRA GLP Compliance Programme, and to enhance transparency and understanding of regulatory expectations prior to finalisation.
- GLP test facilities (listed, applying, or previously inspected)
- Study sponsors, including pharmaceutical/medical device companies and contract research organisations
- Quality assurance personnel and GLP professionals
- Regulatory authorities and relevant government agencies
- Industry associations and professional bodies
- Academic and research institutions conducting non-clinical studies
- International stakeholders subject to NPRA GLP compliance monitoring
UPC Technical Assistant
Have Your Say
Share your thoughts and feedback
Engage with stakeholders and provide administrative oversight on feedback.
No comments yet
Survey
Please indicate the relevant line number(s) of the draft Malaysian Guideline for NPRA GLP Compliance Programme that you wish to comment on, followed by your comments or suggested amendments in the space provided. Each comment should be clearly linked to the corresponding line number to facilitate review and consolidation.
The cooperation of Dato'/Datin/Dr./Sir/Madam is requested to complete ALL the details in the survey. All information is confidential and will be used for the purpose of this public consultation session only. We would like to thank you for your time and effort in providing feedback.
Please click on the button below to contribute your comment to this consultation.